0001209191-22-004394.txt : 20220121 0001209191-22-004394.hdr.sgml : 20220121 20220121160736 ACCESSION NUMBER: 0001209191-22-004394 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220114 FILED AS OF DATE: 20220121 DATE AS OF CHANGE: 20220121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paul Bernard H CENTRAL INDEX KEY: 0001906043 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 22546014 MAIL ADDRESS: STREET 1: 300 WASHINGTON STREET STREET 2: ONE GATEWAY CENTER, SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-14 0 0001069308 Acer Therapeutics Inc. ACER 0001906043 Paul Bernard H C/O ACER THERAPEUTICS INC. ONE GATEWAY CENTER, SUITE 351 NEWTON MA 02458 0 1 0 0 Chief People Officer Employee Stock Option (right to buy) 2.21 2022-01-14 4 A 0 25000 0.00 A 2032-01-14 Common Stock 25000 25000 D The option vests and becomes exercisable over four years as follows: 25% of the shares vest on January 14, 2023, and the remaining 75% of the shares vest quarterly over the remaining three years. /s/ Harry S. Palmin, Attorney-in-Fact 2022-01-21